There’s no doubt the world is desperately in need of vaccines. Seattle Vaccine Trials Unit (VTU) is leading the fight against major diseases of today such as COVID-19 and HIV/AIDS. We pursue innovative research strategies to promote heathier protected communities.
You can make an impact by joining one of our research studies for COVID-19 or HIV.
We need volunteers to help move science toward more discoveries. Sign up now to see if you can help with one of our studies.
Currently, we are only enrolling people with confirmed COVID-positive results from the last 30 days. Our COVID observational studies will help us gain an understanding of how the immune system works in response to COVID, and enable us to find better ways to prevent and treat the virus.
At this time all our COVID studies are observational, no medication or vaccines are given. Learn more about the Seattle COVID-Cohort Study.
We are enrolling healthy, HIV-negative volunteers for HIV vaccine studies that are being coordinated by networks such as the HIV Vaccine Trials Network and the International AIDS Vaccine Initiative. The products used in all our studies are NOT produced from live HIV or from HIV-infected human cells. These study vaccines cannot cause HIV infection.
Additionally, we have a number of observational HIV studies to help us learn more about the immune system in people who have HIV but are able to naturally control the virus. There are no medications or vaccines given in our observational studies.
Our work would not be possible without a dedicated community of collaborating organizations volunteers and donors.
A History of Collaboration — Some of our longstanding partners include African American Reach and Teach Ministries, Entre Hermanos, Gay City, POCAAN and Lifelong. Many of our HIV vaccine studies are in partnership with global networks such as the HIV Vaccine Trials Network and the International AIDS Vaccine Initiative, and many local public health officials and service organizations helped to establish a foundation for our COVID-19 research during the pandemic.
Inspired by Community — The VTU is committed to fostering and maintaining meaningful, collaborative, and mutually beneficial relationships with our community partners and study volunteers. We are especially grateful to the many people who have helped move our research forward, and for the insights and partnership of our Community Advisory Board members. We respect cultural values and diversity, and we maintain broad-minded perspectives among our staff and advisors.
Donor-powered — During the COVID-19 pandemic, Fred Hutch was able to rapidly deploy leading-edge research efforts to control the virus, thanks in part to the generous philanthropic support from individual donors and companies. Our COVID-Cohort study appreciates our local first responders and community members who joined our study and helped us to better understand how COVID impacts immune systems.
As a parent, part of the reason I do this research is to create a brighter future for my son's generation. It makes my work that much more important to me.
— Julie McElrath, Principal Investigator, Seattle VTU
Translating the Language of Immunity
An advocate for equitable representation in science, doctoral student Nick Maurice was awarded the 2021 Graduate School Medal
UW Graduate School | May 26, 2021
People who have had COVID should get single vaccine dose, studies suggest
New studies show that one shot of a vaccine can greatly amplify antibody levels in those who have recovered from the coronavirus.
New York Times | Feb. 19, 2021
IAVI and Moderna partner to tackle broad global health priorities using mRNA for vaccines and antibodies
IAVI | News Release | April 7, 2022
Trial of innovative HIV vaccine using mRNA technology enrolls first participant
HVTN | New Release | March 14, 2022